Insights of Post-Operative Pain Pipeline for Key Company Profiles H2 2017 The latest Pharmaceutical and Healthcare disease pipeline guide Post-Operative Pain Pipeline Review, H2 2017, provides an overview of the Post-Operative Pain (Central Nervous System) pipeline landscape. For more info https://goo.gl/Tqd9wx Pain is one of the main postoperative adverse outcomes causing distress to patients. Degree of postoperative pain experienced by individuals varies. Cause of pain includes peripheral nerve damage during surgery, inflammation at the site of the wound and damage to bodily tissues during surgery. Risk factors include site of the operation, age, level of fear or anxiety, surgical procedure, personal preference and response to agents given. Treatment for post-operative pain includes analgesia and anesthetics. The Pharmaceutical and Healthcare latest pipeline guide Post-Operative Pain Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Post-Operative Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Get the Single user and Corporate License here at https://goo.gl/Khfkaj The Post-Operative Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Post-Operative Pain and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 2, 1, 10, 16, 8, 14, 3 and 2 respectively. Similarly, the Universities portfolio in Phase III and Preclinical stages comprises 1 and 1 molecules, respectively. Post-Operative Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. Scope
Insights of Post-Operative Pain Pipeline for Key Company Profiles H2 2017 - The pipeline guide provides a snapshot of the global therapeutic landscape of Post-Operative Pain (Central Nervous System). - The pipeline guide reviews pipeline therapeutics for Post-Operative Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources. - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. - The pipeline guide reviews key companies involved in Post-Operative Pain (Central Nervous System) therapeutics and enlists all their major and minor projects. - The pipeline guide evaluates Post-Operative Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. - The pipeline guide encapsulates all the dormant and discontinued pipeline projects. - The pipeline guide reviews latest news related to pipeline therapeutics for Post-Operative Pain (Central Nervous System) Inquire for the report at https://goo.gl/qAVHef Post-Operative Pain - Companies Involved in Therapeutics Development Abide Therapeutics Inc AcelRx Pharmaceuticals Inc Adynxx Inc AngioChem Inc Aoxing Pharmaceutical Company Inc Camurus AB Cara Therapeutics Inc Center Laboratories Inc Colby Pharmaceutical Company Cytogel Pharma LLC Dompe Farmaceutici SpA DURECT Corp Eupraxia Pharmaceuticals Inc EyeGate Pharmaceuticals Inc Fujimoto Pharmaceutical Corp GW Pharmaceuticals Plc Heron Therapeutics Inc Immupharma Plc Innocoll AG Insys Therapeutics Inc
Insights of Post-Operative Pain Pipeline for Key Company Profiles H2 2017 Lipocure Ltd Liquidia Technologies Inc Medtronic Plc Mundipharma International Ltd Novartis AG Orion Oyj Pacira Pharmaceuticals Inc PainReform Ltd PhytoHealth Corp PixarBio Corp Proteus SA Recro Pharma Inc Relmada Therapeutics Inc Serina Therapeutics Inc SteadyMed Therapeutics Inc Teikoku Pharma USA Inc The Medicines Company Trevena Inc Xigen SA